• Cristina Domingo, Fernando Aros, Agurtzane Otxandategi, Idoia Beistegui, Ariadna Besga, Pedro María Latorre, and En representación de los investigadores del grupo PROMIC.
• Medicina Familiar y Comunitaria, Gerencia de Atención Primaria del Servicio Cántabro de Salud, Santander, España. Electronic address: Cristina.domingo@scsalud.es.
• Aten Primaria. 2019 Mar 1; 51 (3): 142152142-152.

ObjectiveTo assess the efficacy of the ProMIC, multidisciplinary program for patients admitted at hospital because of heart failure (HF) programme, in reducing the HF-related readmission rate.DesingQuasi-experimental research with control group.SettingsTwelve primary health care centres and 3 hospitals from the Basque Country.ParticipantsAged 40 years old or above patients admitted for HF with a New York Heart Association functional class II to IV.InterventionsPatients in the intervention group carried out the ProMIC programme, a structured clinical intervention based on clinical guidelines and on the chronic care model. Control group received usual care.Main MeasurementsThe rate of readmission for HF and health-related quality of life RESULTS: One hundred fifty five patients were included in ProMIC group and 129 in control group. 45 rehospitalisation due to heart failure happened in ProMIC versus 75 in control group (adjusted hazard ratio=0.59, CI 95%: 0.36-0.98; P=.049). There were significant differences in specific quality of life al 6 months. No significant differences were found in rehospitalisation due to all causes, due to cardiovascular causes, visits to emergency room, mortality, the combined variable of these events, the functional capacity or quality of life at 12 months of follow up.ConclusionsProMIC reduces significantly heart failure rehospitalisation and improve quality of life al 6 months of follow up. No significant differences were found in the rests of variables.Copyright © 2018 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.

18 keywords...

hide…